Showing results (891-900 of 934) with videos related to

Sort By:
Pageof 94
Journal of Neurology|March 2, 2026
Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE studyRoberto Bergamaschi, Ottavia Eleonora Ferraro, Pisoni Enrico, et al.
The Lancet. Infectious Diseases|June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trialIvan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
European Journal of Neurology|December 11, 2020
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre studyMaria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, et al.
The New England Journal of Medicine|September 22, 2021
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M El Sahly, Lindsey R Baden, Brandon Essink, et al.
CNS Drugs|January 28, 2026
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter StudyGianmarco Abbadessa, Damiano Marastoni, Floriana Bile, et al.
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
The New England Journal of Medicine|October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeEvan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.
Journal of Neurology|February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 12, 2024
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancyDoriana Landi, Silvia Bartolomeo, Francesca Bovis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisYi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Pageof 94